Literature DB >> 34773162

Preparation and Characterization of pH-Independent Sustained-Release Tablets Containing Hot Melt Extruded Solid Dispersions of Clarithromycin : Tablets Containing Solid Dispersions of Clarithromycin.

Qazi Amir Ijaz1, Sumera Latif2, Qurat-Ul-Ain Shoaib1, Memoona Rashid1, Muhammad Sohail Arshad3, Amjad Hussain1, Nadeem Irfan Bukhari1, Sohail Riaz4, Nasir Abbas5.   

Abstract

The limited solubility of clarithromycin (CAM), coupled with low bioavailability and rapid elimination, are major shortcomings, needed to be addressed to achieve optimum therapeutic goals. Therefore, sustained-release (SR) tablets containing solid dispersion (SD) granules of CAM were prepared in this study. Initially, SD granules of CAM were prepared by hot melt extrusion (HME) technique using Kollidon VA64 as a hydrophilic carrier. The saturation solubility of SD showed almost 4.5-fold increase as compared to pure CAM in pH 6.8 medium. In vitro drug dissolution data indicated a substantial increase in the dissolution of SD as compared to that of pure CAM. The thermal stability of drug, carrier, and SD at elevated HME temperatures was evident from the results of thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). Powder X-ray diffraction (PXRD) data and scanning electron microscope (SEM) images revealed a decrease in the crystallinity and the uniform dispersion of drug, respectively. Moreover, Fourier transformed infrared spectroscopy (FT-IR) data confirmed the formation of hydrogen bond between the carbonyl group of drug and the hydroxyl group of carrier. SD loaded sustained-release (SD-SR) matrix tablets were prepared with hydrophobic polymers (Eudragit RS100 and Eudragit RL100). The pH-independent swelling and permeability of both polymers were responsible for the sustained drug release from SD-SR tablets. Pharmacokinetic (PK) studies suggested a 3.4-fold increase in the relative bioavailability of SD-SR tablets as compared to that of pure CAM.
© 2021. American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  Clarithromycin; Hot melt extrusion; Relative bioavailability; Solid dispersions; Sustained-release

Mesh:

Substances:

Year:  2021        PMID: 34773162     DOI: 10.1208/s12249-021-02115-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  30 in total

1.  Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs.

Authors:  Paola Aline Amarante Borba; Marihá Pinotti; Carlos Eduardo Maduro de Campos; Bianca Ramos Pezzini; Hellen Karine Stulzer
Journal:  Carbohydr Polym       Date:  2015-10-23       Impact factor: 9.381

2.  Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.

Authors:  S Sotthivirat; C McKelvey; J Moser; B Rege; W Xu; D Zhang
Journal:  Int J Pharm       Date:  2013-05-04       Impact factor: 5.875

3.  Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.

Authors:  Phuong H L Tran; Beom-Jin Lee; Thao T D Tran
Journal:  Eur J Pharm Biopharm       Date:  2021-04-19       Impact factor: 5.571

4.  Continuous direct compression as manufacturing platform for sustained release tablets.

Authors:  B Van Snick; J Holman; C Cunningham; A Kumar; J Vercruysse; T De Beer; J P Remon; C Vervaet
Journal:  Int J Pharm       Date:  2017-01-06       Impact factor: 5.875

5.  Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus® processed by hot melt extrusion.

Authors:  Ahmad B Albadarin; Catherine B Potter; Mark T Davis; Javed Iqbal; Sachin Korde; Sudhir Pagire; Anant Paradkar; Gavin Walker
Journal:  Int J Pharm       Date:  2017-09-18       Impact factor: 5.875

6.  Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.

Authors:  T R Hörmann; N Jäger; A Funke; R-K Mürb; J G Khinast; A Paudel
Journal:  Int J Pharm       Date:  2018-10-14       Impact factor: 5.875

7.  Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.

Authors:  J Sahoo; P N Murthy; S Biswal
Journal:  AAPS PharmSciTech       Date:  2009-01-15       Impact factor: 3.246

8.  Formulation of a extended release tablet containing dexibuprofen.

Authors:  Hong Gi Yi; Moon Hyuk Chi; Yong-Il Kim; Jong Soo Woo; Eun-Seok Park
Journal:  Arch Pharm Res       Date:  2008-12-20       Impact factor: 4.946

9.  Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.

Authors:  Nian-Qiu Shi; Shu-Ran Wang; Yong Zhang; Jun-Shuang Huo; Li-Na Wang; Jian-Hui Cai; Zheng-Qiang Li; Bai Xiang; Xian-Rong Qi
Journal:  Eur J Pharm Sci       Date:  2019-01-23       Impact factor: 4.384

10.  Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate.

Authors:  Mirjana Krkobabić; Djordje Medarević; Sandra Cvijić; Branka Grujić; Svetlana Ibrić
Journal:  Int J Pharm       Date:  2019-10-31       Impact factor: 5.875

View more
  1 in total

1.  Assessing the Synergistic Activity of Clarithromycin and Therapeutic Oils Encapsulated in Sodium Alginate Based Floating Microbeads.

Authors:  Ikram Ullah Khan; Mehwish Shoukat; Muhammad Asif; Syed Haroon Khalid; Sajid Asghar; Muhammad Usman Munir; Muhammad Irfan; Akhtar Rasul; Sameer H Qari; Alaa T Qumsani; Mohamed M Hassan; Maryam A Alahdal; Muhammad Usman; Zulqurnain Khan
Journal:  Microorganisms       Date:  2022-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.